No photo of Miles Sparrow

View Scopus Profile

Miles Sparrow

Dr

20062021
If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2006 2021

A Phase 3b, Multicenter, Randomized, Blinded, Active-Controlled Study to Compare the Efficacy and Safety of Ustekinumab to that of Adalimumab in the Treatment of Biologic Naive Subjects with Moderately-to-Severely Active Crohn's Disease.

Sparrow, M.

20/12/18 → 20/01/20

Project: Research

A Phase 2/3, Randomized, Double-blind, Placebo- and Active- controlled, Parallel-group, Multicenter Protocol to Evaluate the Efficacy and Safety of Guselkumab in Participants with Moderately to Severely Active Crohn's Disease (GALAXI).

Sparrow, M. & Hogg, J.

4/10/18 → 30/06/21

Project: Research

Research of inflammatory bowel disease in Australia

Gibson, P. & Sparrow, M.

Ferring Pharmaceuticals Pty Ltd

1/01/06 → 31/12/07

Project: Research

Research Output 2007 2018

Examining maintenance care following infliximab salvage therapy for acute severe ulcerative colitis

Seah, D., Choy, M. C., Gorelik, A., Connell, W. R., Sparrow, M. P., Van Langenberg, D., Hebbard, G., Moore, G. & De Cruz, P., 1 Jan 2018, In : Journal of Gastroenterology and Hepatology. 33, 1, p. 226-231 6 p.

Research output: Contribution to journal › Article › Research › peer-review

Open Access
File

Predicting response after infliximab salvage in acute severe ulcerative colitis

Choy, M. C., Seah, D., Gorelik, A., An, Y. K., Chen, C. Y., Macrae, F. A., Sparrow, M. P., Connell, W. R., Moore, G. T., Radford-Smith, G., Van Langenberg, D. R. & De Cruz, P., 1 Jul 2018, In : Journal of Gastroenterology and Hepatology. 33, 7, p. 1347-1352 6 p.

Research output: Contribution to journal › Article › Research › peer-review

Randomised clinical trial: efficacy, safety and dosage of adjunctive allopurinol in azathioprine/mercaptopurine nonresponders (AAA Study)

Friedman, A. B., Brown, S. J., Bampton, P., Barclay, M. L., Chung, A., Macrae, F. A., McKenzie, J., Reynolds, J., Gibson, P. R., Hanauer, S. B. & Sparrow, M. P., 1 Apr 2018, In : Alimentary Pharmacology and Therapeutics. 47, 8, p. 1092-1102 11 p.

Research output: Contribution to journal › Article › Research › peer-review

Adalimumab in ulcerative colitis–efficacy, safety and optimization in the era of treat-to target

Sparrow, M. P., 4 May 2017, In : Expert Opinion on Biological Therapy. 17, 5, p. 613-621 9 p.

Research output: Contribution to journal › Article › Research › peer-review

Anti-MAdCAM antibody (PF-00547659) for ulcerative colitis (TURANDOT): a phase 2, randomised, double-blind, placebo-controlled trial

Vermeire, S., Sandborn, W. J., Danese, S., Hébuterne, X., Salzberg, B. A., Klopocka, M., Tarabar, D., Vanasek, T., Greguš, M., Hellstern, P. A., Kim, J. S., Sparrow, M. P., Gorelick, K. J., Hinz, M., Ahmad, A., Pradhan, V., Hassan-Zahraee, M., Clare, R., Cataldi, F. & Reinisch, W., 8 Jul 2017, In : The Lancet. 390, 10090, p. 135-144 10 p.

Research output: Contribution to journal › Article › Research › peer-review